Merozan Indications/Uses

Meropenem (Merozan) is indicated for treatment, in adults and children, of the following infections caused by single or multiple bacteria sensitive to meropenem.
Nosocomial pneumonias, pneumonias in immunosuppressed patients, pneumonias not responding to other antibacterial treatments, due to bacteria susceptible to meropenem according to the susceptibility test; Urinary tract infections (complicated and non-complicated); Intra-abdominal infections; Gynaecological infections, such as endometritis and pelvic inflammatory disease; Infections of the skin and soft tissues; Meningitis; Septicaemia; Empiric treatment, for presumed infections in adult patients with febrile neutropenia.
Intravenous meropenem has been used effectively in patients with cystic fibrosis and chronic lower respiratory tract infections, either as monotherapy or in combination with other antibacterial agents. Eradication of the organism was not always established. It is also indicated, in children over 3 months of age, for the treatment of the above mentioned infections apart from gynaecological infections, infections of the skin and soft tissues and the non-complicated urinary tract infections. Meropenem (Merozan) has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections.